Cardiol Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
24 Jun 24 | BuyUS$101,439 | David Elsley | Individual | 50,000 | US$2.03 |
Insider Trading Volume
Insider Buying: CRDL insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 15,005 | 0.0219% |
Individual Insiders | 3,177,370 | 4.65% |
Institutions | 6,674,685 | 9.76% |
General Public | 58,506,253 | 85.6% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 6.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
2,566,125 | US$5.1m | -13.1% | 0.48% | |||
1,644,410 | US$3.3m | 47.3% | 1.21% | |||
1,301,978 | US$2.6m | 9.41% | 0.49% | |||
1,204,500 | US$2.4m | 4.33% | no data | |||
771,336 | US$1.5m | 0% | no data | |||
467,290 | US$933.2k | 0% | no data | |||
239,380 | US$478.0k | 0% | no data | |||
192,700 | US$384.8k | 0% | 0.15% | |||
152,364 | US$304.3k | 70.9% | no data | |||
142,500 | US$284.6k | 72.7% | no data | |||
128,743 | US$257.1k | 51.1% | no data | |||
110,000 | US$219.7k | 0% | no data | |||
100,000 | US$199.7k | 0% | 0.01% | |||
100,000 | US$199.7k | 0% | 0.03% | |||
80,000 | US$159.8k | 0% | no data | |||
80,000 | US$159.8k | 0% | 0.05% | |||
60,398 | US$120.6k | 0% | no data | |||
60,000 | US$119.8k | 0% | no data | |||
52,435 | US$104.7k | 0% | no data | |||
50,000 | US$99.9k | -52.1% | no data | |||
45,669 | US$91.2k | 0% | no data | |||
36,900 | US$73.7k | 0% | 0.01% | |||
30,000 | US$59.9k | 0% | no data | |||
25,380 | US$50.7k | 0% | no data | |||
23,500 | US$46.9k | 0% | no data |